Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0286 per EA under NDC 69097083305. Its NADAC has been published 507 times since Oct 12, 2016.
Strength
25 mg/1
Manufacturer
Cipla USA Inc.NDC
69097083305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077397On Market Since
7/21/2016
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 507 times since Oct 12, 2016, and over the history we have for it it has declined 43.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0286 per EA |
|---|---|
| All-time high | $0.0786 (Sep 16, 2020) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0336 |
| 52-week low | $0.0286 |
| Median price | $0.0554 |
| Average price | $0.0513 |
| Largest weekly change | +31.1% (Jul 22, 2020) |
| Weeks tracked | 507 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Cipla USA Inc., is $0.0286 per EA (NDC 69097083305), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 43.0%. It has been tracked across 507 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Oct 12, 2016, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.0786 (Sep 16, 2020), with a median of $0.0554 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 69097083305) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification